OLEIC ACID

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
281.0 4.8 0 2 40.0 15 0.83
UNII
2UMI9U37CP
CAS
112-80-1
SYNONYMS
  • Oleic Acid
  • Cis-9-Octadecenoic Acid
  • Fema No. 2815
  • Oleic Acid [ep]
  • Oleic Acid [mart.]
  • Oleic Acid [mi]
  • Oleic Acid [inci]
  • Oleic Acid [fhfi]
  • Oleic Acid [fcc]
  • Oleate
  • Oleic Acid [ii]
  • Oleic Acid [hsdb]
  • Oleic Acid [usp-Rs]
  • Oleic Acid [who-Dd]
  • Oleic Acid [vandf]
  • 9-Octadecenoic Acid (9z)-
  • 9z-Octadecenoic Acid
  • 18:1(n-9)
  • Priolene 6936
  • Vopcolene 27
  • Wecoline Oo
  • Oleic Acid (constituent Of Evening Primrose Oil) [dsc]
  • Oleic Acid (constituent Of Flax Seed Oil) [dsc]
  • Oleic Acid (constituent Of Saw Palmetto) [dsc]
  • Oleic Acid (constituent Of Spirulina) [dsc]
  • Oleic Acid (c18:1) (constituent Of Krill Oil) [dsc]
  • Oleic Acid (constituent Of Borage Seed Oil) [dsc]
  • Nsc-9856
ZINC ID(s)
Availability
Present in 78 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
FABP3 Fatty acid-binding protein, heart Auxiliary Transport Protein / Atp-Fabp
PPARG Peroxisome proliferator-activated receptor gamma Transcription Factor / Nr
FABP1 Fatty acid-binding protein, liver Unclassified / Unclassified
FABP5 Fatty acid-binding protein, epidermal Auxiliary Transport Protein / Atp-Fabp
FABP4 Fatty acid-binding protein, adipocyte Auxiliary Transport Protein / Atp-Fabp
PPARD Peroxisome proliferator-activated receptor delta Unclassified / Unclassified
FAAH Fatty-acid amide hydrolase 1 Enzyme / Enzyme-Other
PPARA Peroxisome proliferator-activated receptor alpha Transcription Factor / Nr

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT01661764 2012-09-01 Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention Phase 2 Recruiting
NCT01674946 2011-09-01 Effect of Bile Acids on the Secretion of Satiation Peptides in Humans Phase 1 Completed
NCT00059254 2000-09-01 Differential Metabolism of Dietary Fatty Acids Phase 1 Completed

(Browse) Purchasable Analogs in ZINC

Regulatory Status of Oleic Acid

Gras - Generally recognized as safe.

Products Using Oleic Acid

Download
APIs Products incorporating these APIs
Dextroamphetamine Sulfate Dextroamphetamine Sulfate(RX) , Dextroamphetamine Sulfate(RX) , Dextroamphetamine Sulfate Extended-Release(RX) , Dextroamphetamine Sulfate Extended-Release(RX)
Verapamil Hydrochloride Verapamil Hydrochloride Pm(RX) , Verapamil Hydrochloride(RX) , Verapamil Hydrochloride(RX) , Verapamil Hydrochloride(RX)
Ritonavir Norvir(RX)
Methylphenidate Hydrochloride Methylphenidate Hydrochloride Extended-Release(RX) , Methylphenidate Hydrochloride Extended-Release(RX)
Tolterodine Tartrate Tolterodine Tartrate(RX) , Detrol La(RX) , Tolterodine Tartrate(RX) , Detrol La(RX) , Detrol La(RX) , Detrol La(RX) , Tolterodine Tartrate Extended Release(RX) , Detrol La(RX) , Tolterodine Tartrate(RX)
Testosterone Fortesta(RX) , Testosterone(RX)
Diltiazem Hydrochloride Diltiazem Hydrochloride(RX) , Diltiazem Hydrochloride(RX) , Diltiazem Hydrochloride(RX) , Diltiazem Hydrochloride(RX) , Diltiazem Hydrochloride(RX) , Diltiazem Hydrochloride(RX)
Guanfacine Hydrochloride Guanfacine Hydrochloride(RX)
Acetazolamide Acetazolamide(RX)
Carbamazepine Carbamazepine(RX)
Divalproex Sodium Divalproex Sodium(RX) , Divalproex Sodium(RX) , Divalproex Sodium(RX) , Divalproex Sodium(RX) , Divalproex Sodium(RX) , Divalproex Sodium(RX) , Divalproex Sodium(RX) , Divalproex Sodium(RX) , Divalproex Sodium(RX)
Chlorpheniramine Maleate Chlor-Trimeton 12 Hour(DISCN)
Omeprazole Omeprazole(RX) , Omeprazole(RX) , Omeprazole(RX) , Omeprazole(RX) , Omeprazole(RX) , Omeprazole(RX) , Omeprazole(RX)
Donepezil Hydrochloride , Memantine Hydrochloride Namzaric(RX)
Imiquimod Imiquimod(RX) , Imiquimod(RX) , Imiquimod(RX)
Memantine Hydrochloride Namenda Xr(RX) , Namenda Xr(RX) , Namenda Xr(RX) , Namenda Xr(RX) , Namenda Xr(RX) , Namenda Xr(RX)
Levetiracetam Levetiracetam(RX)

Dosages

Route Formulation Per Unit Dose
Inhalation Aerosol, Metered 0.27%
Intravenous Emulsion, Injection 0.03%
Nasal Aerosol, Metered 0.13%
Respiratory (inhalation) Aerosol, Metered 0.0003%
Topical Emulsion
Topical Emulsion, Cream 25%
Topical Gel 2.5%
Topical Solution 7.4%
Transdermal Film, Controlled Release 22MG
Transdermal Patch, Controlled Release 5.51MG
Oral Aerosol, Metered 4E-7%
Oral Capsule, Soft Gelatin 598.6MG
Oral Inhalation 0.0004%
Oral Tablet, Coated 0.72MG
Oral Tablet, Extended Release
Oral Tablet, Film Coated
Oral Tablet, Repeat Action 1.85MG
Oral Tablet, Sustained Action 2MG

More Information

Usage Over Time

Comments